These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20813656)

  • 21. [Sarcomas management network in France].
    Gouin F; Lacroix H
    Bull Cancer; 2010 Jun; 97(6):621-5. PubMed ID: 20488779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of research collaborations and consortia in rare cancers.
    Blay JY; Coindre JM; Ducimetière F; Ray-Coquard I
    Lancet Oncol; 2016 Feb; 17(2):e62-e69. PubMed ID: 26868355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statistical genomics in rare cancer.
    Abbas-Aghababazadeh F; Mo Q; Fridley BL
    Semin Cancer Biol; 2020 Apr; 61():1-10. PubMed ID: 31437624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A unifying strategy for clinical trials in rare urological malignancy.
    Nicholson S
    Nat Clin Pract Urol; 2008 Dec; 5(12):652-3. PubMed ID: 19015645
    [No Abstract]   [Full Text] [Related]  

  • 25. [Austrian and European initiatives in the field of rare diseases perspectives for a "marginal group" of many millions of patients].
    Laimer M; Prodinger C; Ahlgrimm-Siess V; Hintner H; Bauer JW
    J Dtsch Dermatol Ges; 2015 Mar; 13(3):261-4. PubMed ID: 25721645
    [No Abstract]   [Full Text] [Related]  

  • 26. [Major advances in oncology in 2014: the editorial board of the Bulletin du Cancer point of view].
    Massard C; Bay JO; André T; Blay JY; Goncalves A; Orbach D; Wislez M; Thariat J; Magné N; Vignot S
    Bull Cancer; 2015 Jan; 102(1):92-104. PubMed ID: 25609486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rare diseases, definitions and epidemiology].
    Donnart A; Viollet V; Roinet-Tournay M
    Soins Pediatr Pueric; 2013; (274):14-6. PubMed ID: 24228328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Networking for children and adolescents with very rare tumors: foundation of the GPOH Pediatric Rare Tumor Group.
    Brecht IB; Graf N; Schweinitz Dv; Frühwald MC; Bielack SS; Schneider DT
    Klin Padiatr; 2009; 221(3):181-5. PubMed ID: 19437371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Volume 100, number 6 of our journal, Bulletin du Cancer].
    Bay JO
    Bull Cancer; 2013 Jun; 100(6):533. PubMed ID: 23923513
    [No Abstract]   [Full Text] [Related]  

  • 30. [Which recent results in Oncology and Hematology will have an impact on our practices? The point of vue of Bulletin du Cancer editorial board].
    Vignot S; André T; Gonçalves A; Guièze R; Magné N; Orbach D; Penel N; Thariat J; Wislez M; Bay JO
    Bull Cancer; 2017 Jan; 104(1):6-19. PubMed ID: 28007296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Rare diseases are not orphan any longer].
    Cordier JF
    Rev Prat; 2012 Jan; 62(1):3. PubMed ID: 22335057
    [No Abstract]   [Full Text] [Related]  

  • 32. Managing drugs for rare genetic diseases: trends and insights.
    Zitter M
    Manag Care; 2005 Feb; 14(2):52-4, 57-60, 63-4; quiz 66-7. PubMed ID: 15782848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Management of cancer patients, what has changed?].
    Alby N
    Soins; 2005 Mar; (693):49. PubMed ID: 15796483
    [No Abstract]   [Full Text] [Related]  

  • 34. CEMARA: a Web dynamic application within a N-tier architecture for rare diseases.
    Messiaen C; Le Mignot L; Rath A; Richard JB; Dufour E; Ben Said M; Jais JP; Verloes A; Le Merrer M; Bodemer C; Baujat G; Gerard-Blanluet M; Bourdon-Lanoy E; Salomon R; Ayme S; Landais P
    Stud Health Technol Inform; 2008; 136():51-6. PubMed ID: 18487707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Orphanet, an information site on rare diseases].
    Aymé S
    Soins; 2003; (672):46-7. PubMed ID: 12655825
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bibliographic elements. Cancer, towards a new management].
    Régent L
    Soins; 2005 Mar; (693):50. PubMed ID: 15796484
    [No Abstract]   [Full Text] [Related]  

  • 37. [The French rare diseases plan and learned society: situation in pediatric hematology and immunology].
    Donadieu J
    Arch Pediatr; 2010 Jun; 17(6):729-30. PubMed ID: 20654863
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative.
    Bogaerts J; Sydes MR; Keat N; McConnell A; Benson A; Ho A; Roth A; Fortpied C; Eng C; Peckitt C; Coens C; Pettaway C; Arnold D; Hall E; Marshall E; Sclafani F; Hatcher H; Earl H; Ray-Coquard I; Paul J; Blay JY; Whelan J; Panageas K; Wheatley K; Harrington K; Licitra L; Billingham L; Hensley M; McCabe M; Patel PM; Carvajal R; Wilson R; Glynne-Jones R; McWilliams R; Leyvraz S; Rao S; Nicholson S; Filiaci V; Negrouk A; Lacombe D; Dupont E; Pauporté I; Welch JJ; Law K; Trimble T; Seymour M
    Eur J Cancer; 2015 Feb; 51(3):271-81. PubMed ID: 25542058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Children's Oncology Group's 2013 blueprint for research: rare tumors.
    Rodriguez-Galindo C; Krailo M; Frazier L; Chintagumpala M; Amatruda J; Katzenstein H; Malogolowkin M; Spector L; Pashankar F; Meyers R; Tomlinson G;
    Pediatr Blood Cancer; 2013 Jun; 60(6):1016-21. PubMed ID: 23255219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rare cancers in children - The EXPeRT Initiative: a report from the European Cooperative Study Group on Pediatric Rare Tumors.
    Bisogno G; Ferrari A; Bien E; Brecht IB; Brennan B; Cecchetto G; Godzinski J; Orbach D; Reguerre Y; Stachowicz-Stencel T; Schneider DT
    Klin Padiatr; 2012 Oct; 224(6):416-20. PubMed ID: 23143769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.